Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Dow
Boehringer Ingelheim
AstraZeneca
Moodys

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Drug Price Trends for MEPROBAMATE

See Plans and Pricing

« Back to Dashboard

Drug Price Trends for MEPROBAMATE

Average Pharmacy Cost for MEPROBAMATE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
MEPROBAMATE 400 MG TABLET 23155-0129-01 2.78736 EACH 2019-01-23
MEPROBAMATE 400 MG TABLET 55111-0641-01 2.78736 EACH 2019-01-23
MEPROBAMATE 400 MG TABLET 62332-0020-31 2.78736 EACH 2019-01-23
MEPROBAMATE 400 MG TABLET 23155-0129-01 2.93032 EACH 2018-10-17
MEPROBAMATE 400 MG TABLET 55111-0641-01 2.93032 EACH 2018-10-17
MEPROBAMATE 400 MG TABLET 62332-0020-31 2.93032 EACH 2018-10-17
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Baxter
Dow
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.